Department of Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, United Kingdom.
East Mediterr Health J. 2013 Apr;19(4):373-81.
This survey examined current patient awareness and understanding of generic substitution. We surveyed 188 renal patients using 36 multiple-choice questions in 2 hospitals in the United Arab Emirates. We found that 70% of patients were aware of the availability of generic medicines, 60% understood the terms "generic" and "branded" in relation to medicines and 64% were conscious of generic substitution practice. However, 32% did not know if they were taking generics and 31% felt that generics were not equivalent or only sometimes equivalent to branded medicines. Nearly half (47%) the patients stated they would refuse generic substitution of ciclosporin when it became available if this was just to save the health authority money. In our opinion, random generic substitution should not be implemented because there is still uncertainty and lack of knowledge among patients.
这项调查研究了当前患者对仿制药替代的认知和理解。我们在阿联酋的两家医院用 36 个多项选择题对 188 名肾病患者进行了调查。我们发现，70%的患者知道有仿制药，60%的患者理解药品相关的“通用”和“品牌”术语，64%的患者了解仿制药替代的做法。然而，32%的患者不知道他们正在服用仿制药，31%的患者认为仿制药与品牌药不等效或只有在某些时候等效。近一半（47%）的患者表示，如果环孢素可以进行仿制药替代以节省卫生部门的资金，他们将拒绝这种替代。在我们看来，不应该随机实施仿制药替代，因为患者仍然存在不确定性和知识缺乏的问题。
